1.
Sotiriou E, Tsentemeidou A, Sideris N, Lallas A, Kougkas N, Ioannides D, et al. Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre. Dermatol Pract Concept [Internet]. 2022 May 2 [cited 2026 Apr. 19];12(2):e2022076. Available from: https://mail.dpcj.org/index.php/dpc/article/view/1907